Ecuador issues a compulsory license on abacavir/lamivudine on 12 November 2012
On 12 November 2012, Ecuador issued a compulsory license on abacavir/lamivudine. (attached here) This follows the issuance of Ecuador’s first compulsory license in 2009 on ritonavir/lopinavir. Continue Reading